{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Kiniksa Pharmaceuticals, Ltd."},"Symbol":{"label":"Symbol","value":"KNSA"},"Address":{"label":"Address","value":"2 CHURCH STREET,CLARENDON HOUSE, HAMILTON, HM11, Bermuda"},"Phone":{"label":"Phone","value":"+44 8081896257"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404."},"CompanyUrl":{"label":"Company Url","value":"https://www.kiniksa.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Eben P. Tessari","title":"Chief Operating Officer & Senior Vice President"},{"name":"John F. Paolini","title":"Chief Medical Officer & Senior Vice President"},{"name":"Sanj K. Patel","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}